<DOC>
	<DOCNO>NCT01922349</DOCNO>
	<brief_summary>Safety , tolerability pharmacokinetics single multiple oral dos BI 113608 healthy Chinese , Japanese Caucasian male volunteer .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics BI 113608 Healthy Asian Caucasian Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Healthy male volunteer accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( Blood Pressure , Pulse Rate ) , 12lead Electrocardiogram , clinical laboratory test Chinese ethnicity , Japanese ethnicity accord follow criteria Japanese ; bear Japan , current Japanese passport holder , live outside Japan &lt; 10 year , parent grandparent born Japan Chinese ; ethnic Chinese , born China ethnic Chinese born outside China , descendent 4 ethnic Chinese grandparent bear China Caucasian Age old 20 young 45 year Normal lung function test Normal peripheral oxygen saturation determine noninvasive pulse oxymetry Body Mass Index 18.5 Body Mass Index less 25 kg/m2 Japanese Chinese Body Mass Index 18.5 Body Mass Index less 29.9 kg/m2 Caucasians Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation . Exclusion criterion : Any find medical examination ( include Blood Pressure , Pulse Rate Electrocardiogram ) deviate normal clinical relevance Any evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( include limit kind seizure , migraine , stroke psychiatric disorder ) within past 6 month History relevant orthostatic hypotension , faint spell blackout . Chronic relevant acute infection History relevant allergy/hypersensitivity ( include allergy drug excipients ) Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial Use drug might reasonably influence result trial prolong QT/QTc interval base knowledge time protocol preparation within 10 day prior administration trial Participation another trial investigational drug within two month prior administration trial Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( 20 g/day ) Drug abuse Blood donation ( 100 mL within four week prior administration trial ) Excessive physical activity ( within one week prior administration trial ) Any laboratory value outside reference range clinical relevance Inability comply dietary regimen trial site A marked baseline prolongation QT/QTc interval ( e.g. , repeated demonstration QTc interval &gt; 450 m ) ; A history additional risk factor Torsades de pointes ( e.g. , heart failure , hypokalemia , family history Long QT Syndrome )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>